Navigation Links
Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
Date:5/6/2012

Philadelphia, PA, May 7, 2012 While active monitoring of serum prostate specific antigen (PSA) levels in men over 50 has greatly improved early detection of prostate cancer, prediction of clinical outcomes after diagnosis remains a major challenge. Researchers from the University of Pittsburgh School of Medicine have found that a genetic abnormality known as copy number variation (CNV) in prostate cancer tumors, as well as in the benign prostate tissues adjacent to the tumor and in the blood of patients with prostate cancer, can predict whether a patient will experience a relapse, and the nature of the relapse aggressive or indolent. Their report is published in the June issue of The American Journal of Pathology.

Copy number variations are large areas of the genome with either duplicated or missing sections of DNA. "Our analysis indicates that CNV occurred in both cancer and non-cancer tissues, and CNV of these tissues predicts prostate cancer progression," says lead investigator Jian-Hua Luo, MD, PhD, associate professor in the Divisions of Molecular and Cellular Pathology, and Anatomic Molecular Pathology, Department of Pathology, University of Pittsburgh School of Medicine. "Prediction models of prostate cancer relapse, or of the rate of PSA level increase after surgery, were generated from specific CNV patterns in tumor or benign prostate tissues adjacent to cancer samples."

To detect the abnormalities, scientists conducted a comprehensive genome analysis on 238 samples obtained from men undergoing radical prostatectomy: 104 prostate tumor samples, 85 blood samples from patients with prostate cancer, and 49 samples of benign prostate tissues adjacent to a tumor. A third of the samples were from patients exhibiting recurrence with a PSA level increasing at a rapid rate, doubling in less than four months (rapid increases are associated with lethal prostate cancer); a third from patients exhibiting recurrence with a PSA level in
'/>"/>

Contact: David Sampson
ajpmedia@elsevier.com
215-239-3171
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Some women may be genetically predisposed to smoking-related hot flashes
2. Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
3. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
4. Research Gets Closer to Genetic Roots of Glaucoma
5. Genetic variants, tobacco exposure and lung cancer risk
6. Study of half siblings provides genetic clues to autism
7. Certain Genetic Regions May Be Tied to Osteoporosis
8. Head, Body Lice Are Genetically Very Similar
9. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
10. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
11. Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Turks and Caicos Islands, BWI (PRWEB) May 02, 2015 ... a new website! It is http://www.thevenetiangracebay.com , ... itself, and it incorporates the stunning white and attractive ... to a study of Google, sixty seven percent of ... The study showed that smartphones were used in ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Jusuru International ... for the successful repositioning of its flagship nutritional supplement, ... brand with a new name, new logo, new packaging, ... Ethos Awards are designed to identify and promote programs ... best. , “DSA congratulates Jusuru International for their ...
(Date:5/1/2015)... 2015 The Workgroup for Electronic ... on the use of health IT to create efficiencies ... resource to the United States Government Accountability Office (GAO) ... cards in Medicare. The report, “ Potential Uses of ... released to the public on Apr. 24, 2015 and ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members in both ... for telemedicine. , “Such action is unprecedented in ... said Jonathan Linkous, CEO of the American Telemedicine Association (ATA). ... embrace the use of telecommunications in the delivery of care. ... to improve quality, access, equity and affordability of healthcare.”, ...
(Date:5/1/2015)... KY (PRWEB) May 01, 2015 Ernst ... CEO, Dr. Joshua Rosenthal, Co-Founder & CSO, and Burak ... finalists for the EY Entrepreneur Of The Year® ... Ernst & Young is a global leader in ... to be one of the top audit companies ...
Breaking Medicine News(10 mins):Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... This release is available in Spanish . ... the same area as the original tumour remains the strongest, ... patients who have been free of disease for a very ... seventh European Breast Cancer Conference (EBCC7). Dr Sven Mieog, ...
... Milan, Italy, 24 March 2010 - Despite the aches and ... a positive outlook, remembering the positive experiences from their past. ... of Elsevier,s Cortex ( http://www.elsevier.com/locate/cortex ), reveals that ... lens is linked to the way in which the brain ...
... ... normal guides on how to assemble a hookah, a free video series demonstrating the ... ... go-to for information, TheHookahMonster.com’s marketing director, Mario Ferazzano, has decided to offer a free ...
... is best way to prevent breast cancer deaths , WEDNESDAY, ... does not appear to increase overall survival from the disease, ... instead be due to controlling risk factors and improved treatments, ... as we hoped years ago," said study author Dr. Karsten ...
... A ... Provo, ... 90 program--a new 90 day risk-free offer in the United States to try Tahitian Noni ... the appropriate amount of product for 90 days, then they can get their full purchase price ...
... ... Turn Back the Clock with a Proven, Personalized, Anti-Aging Program". Dr. Karlis Ullis shares how ... www.AskAnAntiAgingExpert.com . , ... March 24, 2010 -- What do the Today show, Hard Copy, Dateline NBC, and Sally ...
Cached Medicine News:Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:Older adults remember the good times 2Health News:TheHookahMonster.com Offers Free Shisha Tobacco Education 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 3Health News:Noni For 90 Offer Made By Tahitian Noni International 2Health News:Free Anti-Aging Teleseminar Teaches People Key Lifestyle Changes To Maximize Longevity 2
(Date:4/30/2015)... April 30, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... with a focus on Omega-3 therapies for cardiovascular ... highlights and financial results for the fiscal year ... herein are in Canadian dollars unless otherwise stated. ... significant, with the right strategic partners and additional ...
(Date:4/30/2015)... , April 30, 2015  IRIDEX Corporation (NASDAQ: ... first quarter 2015 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, May 7, 2015 ... other business developments. Interested parties may access ...
(Date:4/30/2015)... -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) announced today ... after the market closes on Thursday, May 7, 2015.  ... held on Thursday, May 7, 2015, at 4:30 p.m. ... participate in the call, please dial 877-303-1298 (for U.S. ... the teleconference will be available for one week and ...
Breaking Medicine Technology:Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2
... FOREST, Ill., March 9, 2011 Hospira, Inc. (NYSE: ... today announced U.S. Food and Drug Administration (FDA) approval of ... and Hospira expects to launch the product later this month. ... a variety of cancers. In 2010, U.S. sales of Taxotere ...
... Tris Pharma, a specialty pharmaceutical company that develops ... US Food and Drug Administration (FDA) has accepted ... the treatment of allergies in kids two years ... Suspension will provide an alternative to the currently ...
Cached Medicine Technology:Hospira Announces U.S. Approval of Generic Docetaxel 2Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older 2
Cushing Flat Drill, only Component Parts and Accessories for HUDSON Cranial Drill. 14 mm...
Hudson brace only. Component parts and accessories for Hudson cranial drill....
Greenberg micro instrument holder is a flexbar arm used to hold micro instruments used repeatedly within retracted fields. Holds instruments with shafts up to 1/8 in diameter....
Length-9 (229 mm) Tapered retractor blades....
Medicine Products: